Skip to content

14-221 - Specimen Collection From Pregnant Women Who are at Increased Risk for Fetal Chromosome Disorder

Status: open

Collection of Whole Blood Specimens from Pregnant Women at Increased Risk for Fetal Chromosomal Abnormality for use in Development of a Noninvasive Prenatal Test in Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma

Treatment for Fetal Aneuploidy / Down Syndrome

Contact Us


The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21. IRB Number 14-221


This trial is sponsored by Sequenom, Inc..

Providers Associated With This Trial

Principle Investigator

This link will open in a new tab or window.